Related Experiment Videos
Magnetic resonance imaging in primary amyloidosis
Acta Radiologica (Stockholm, Sweden : 1987)
|January 1, 1987
Summary
Magnetic resonance imaging (MRI) can detect amyloidosis (AL) by identifying heart wall thickening and macroglossia. MRI also quantifies amyloid deposits in organs like the liver and spleen, and monitors therapy effectiveness.
Area of Science:
- Radiology
- Cardiology
- Hematology
Background:
- Primary amyloidosis (AL) is a systemic disease characterized by amyloid protein deposition.
- Early detection and monitoring of treatment response are crucial for managing AL.
Purpose of the Study:
- To investigate the utility of magnetic resonance imaging (MRI) in diagnosing and monitoring primary amyloidosis (AL).
- To assess MRI-derived tissue characteristics in patients with AL and correlate them with disease burden and treatment response.
Main Methods:
- A cohort of twelve patients with primary amyloidosis (AL) underwent MRI examinations.
- Quantitative MRI parameters, including T1 and T2 relaxation times, were measured in the liver, spleen, and subcutaneous fat.
- Cardiac MRI was performed to evaluate for cardiac involvement, such as heart wall thickening.
Main Results:
- MRI revealed abnormal heart wall thickening in 9 patients and macroglossia in 2.
- Significantly increased T1 values were observed in the liver and subcutaneous fat, while T2 values were decreased in the spleen.
- Following therapy, T1 values in the liver showed a trend towards normalization in 4 patients.
Conclusions:
- MRI is a valuable non-invasive tool for detecting cardiac manifestations and organ involvement in primary amyloidosis (AL).
- Quantitative MRI parameters can potentially be used to assess amyloid burden and monitor therapeutic efficacy in AL patients.